A phase III adjuvant trial of sequenced EC plus filgrastim plus epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Burnell, MJ
  • Levine, Mark Norman
  • Chapman, JA
  • Bramwell, V
  • Vandenberg, T
  • Chalchal, HI
  • Albain, K
  • Perez, E
  • Rugo, H
  • Pritchard, K

publication date

  • June 20, 2007